State Street Corp ownership in PBYI / Puma Biotechnology Inc - 13F, 13D, 13G Filings - Fintel.io
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference | Business Wire
Pint-Pharma - Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America
PBYI Insider Trading - PUMA BIOTECHNOLOGY Inc - SecForm4.Com
Puma Biotechnology (PBYI) Stock Price, News & Info | The Motley Fool
Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology (PBYI) Scheduled to Post Earnings on Thursday - MarketBeat
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology $PBYI Could Double by the end of May – Stock Market Research, Option Picks, Stock Picks,Financial News,Option Research
Puma Biotechnology (NasdaqGS:PBYI) Stock Price & Quote Analysis - Simply Wall St
Puma Biotechnology Reports Second Quarter 2022 Financial Results
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
This Insider Has Just Sold Shares In Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Puma Biotechnology (NASDAQ:PBYI), Quotes and News Summary - Benzinga
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2022
PBYI Stock Nosedives: Puma Biotechnology's Nerlynx Revenue Falls
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Jobs with Puma Biotechnology
